Daily FNArena News - Australia

New debt covenants mean either a discounted asset sale or a dilutive equity issue for PaperlinX.

Sigma Pharmaceuticals’ first half profit was lower than expected, leading brokers to predict the company will do it tough in meeting its full year targets.

Fortescue’s result fell a little short of broker forecasts, but opinions on the stock remain mixed post the profit announcement.

Consumer inflation expectations in Australia hit a new record high at a time when the RBA started lowering official rates. What’s happening?

The duelling dynamics of weak job ad trends and earning positive acquisitions have brokers split on the prospects of Seek.

While slowing below 10 year trends, Australian domestic demand is still growing.

The acquisition of Eklund Drilling is inarguably good news, but the brokers that are on the fence remain there.

The consumer driven slowdown in the Australian economy is impacting on food retailers in particular, with high food and fuel prices likely to add to pressures.

Alesco has revised down its earnings outlook citing unfavourable conditions and brokers have reacted by cutting price targets for the stock.

The latest read of the Westpac–Melbourne Institute Leading Index is consistent with a weak outlook in the months ahead.